For this 3rd edition of the HealthTech Innovation Days (HTID®), placed under the High Patronage of Mr Emmanuel Macron, President of the French Republic, the European healthcare ecosystem will gather around tomorrow's health major challenges: Artificial Intelligence, health data regulation, impact of the Covid-19 crisis and antibiotic resistance or robotics. The HTID mobilises both international sponsors and European clusters.

PARIS, July 05, 2021 (GLOBE NEWSWIRE) -- The event aims at widely sharing current thinking and actions with leaders in health innovation, global pharmaceutical companies, investors, political representatives and patient organisations. This event, which will again take place in a hybrid format, will also bring together several hundred dedicated healthtech investors and will offer face-to-face and remote meetings between investors from all over the world, European healthtech companies and pharmaceutical groups, with the aim of creating partnerships to speed the time-to-market of innovations for patients. (link to the programme)

The 3rd edition of the HTID benefits from the support of sponsors among major global industrial groups such as Amgen, Bristol-Myers Squibb, Microsoft, Sanofi, Servier, influential players in healthtech, such as Dechert, Financière Arbevel, Icosa, Invest Securities, Sofinnova Partners, as well as institutional partners such as Bpifrance, Euronext and Leem (Les Entreprises du Médicament).

Relations presse
Najette Chaib
najette@outlook.com
+33(0)6 18 38 11 14
EIT Health
Jérôme Fabiano
jerome.fabiano@eithealth.eu
+33(0) 6 42 25 73 41
Sophie Baumont
LifeSci Advisors
sophie@lifesciadvisors.com
+33(0)6 27 74 74 49
   
HTFC
Nathalie Donne
nathalie.donne@insead.eu
+33(0)6 67 67 44 97

HTFC
Solène Goupy
solene.goupy@htfc-eu.com
+33(0)6 38 03 80 19

France Biotech
Florence Portejoie
FP2COM
fportejoie@fp2com.fr
+33(0)6 07 76 82 83